---
figid: PMC8999734__ijms-23-03986-g004
pmcid: PMC8999734
image_filename: ijms-23-03986-g004.jpg
figure_link: /pmc/articles/PMC8999734/figure/ijms-23-03986-f004/
number: Figure 4
figure_title: ''
caption: Schematic representation of Loratadine targeting the AP-1 signaling pathway.
  Loratadine specifically inhibits TAK1 in the AP-1 signaling pathway upon LPS induction,
  thereby suppressing the constituent kinases of the AP-1 pathway and eventually reducing
  the production of pro-inflammatory cytokines.
article_title: Anti-Inflammatory Activities of an Anti-Histamine Drug, Loratadine,
  by Suppressing TAK1 in AP-1 Pathway.
citation: Jiwon Jang, et al. Int J Mol Sci. 2022 Apr;23(7):3986.
year: '2022'

doi: 10.3390/ijms23073986
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- Loratadine
- anti-inflammatory effect
- AP-1
- TAK1

---
